Phase 3
Completed N=126
Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery
Source: ClinicalTrials.gov NCT00703781 ↗Enrolled (actual)
126
Serious AEs
1.6%
Results posted
Dec 2011
Primary outcomePrimary: Number of Participants With Summed Ocular Inflammation Score (SOIS) of Zero — 28; 20 Participants
Summary
Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Summed Ocular Inflammation Score (SOIS) of Zero |
28; 20 | — |
| SECONDARY Number of Participants That Are Pain Free |
51; 46 | — |
Eligibility Criteria
Inclusion Criteria
- Scheduled for cataract surgery
Exclusion Criteria
- Known hypersensitivity to bromfenac and salicylates
Data sourced from ClinicalTrials.gov (NCT00703781). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.